IDENTIFYING CORE BUSINESSES:
ExcellGene: Worked with founders and operations to drive their core biologic cell line business, surpassing revenue targets.
Advanced Instruments: Collaborated with the owner and executive team to differentiate the company’s laboratory equipment, leading to consistent year-over-year revenue growth and exit strategies.
Transgenomic: Teamed up with the founder and M&A team to enhance their core precision medicine business development, resulting in five academic-industry partnerships on innovative diagnostic tools.
COMMERCIAL DUE DILIGENCE:
Advanced Instruments: Confirmed and defined specifications for medical lab equipment and developed Go-to-Market strategies using voice of customer feedback, pricing analysis, and pipeline evaluation.
MilliporeSigma: Performed both quantitative and qualitative market research to identify acquisition targets, assess risks, and develop business and pricing strategies for new initiatives and product launches.
Transgenomic: Conducted market research to evaluate innovative medical diagnostics (IVDs) for alignment with the company's strategic goals.
PRODUCTS AND SERVICES DEVELOPMENT AND LAUNCH:
Advanced Instruments: Led cross-functional teams in R&D, Manufacturing, Quality Assurance, Technical Support, Marketing, and Sales to successfully launch a medical diagnostic device, securing FDA registrations, European CE mark, and Canadian approvals.
Transgenomic: Partnered with renowned thought leaders worldwide on medical diagnostics (IVDs) and laboratory equipment to enhance strategic alignment, resulting in improved pipeline and market penetration.
ALIGNING STRATEGIC GOALS:
ExcellGene: Worked with founders to drive scalability, strategic growth, and exit opportunities in the CDMO sector of the biotech and pharmaceutical industries.
Advanced Instruments: Executed the strategic goals of the investor owners to increase the penetration of laboratory equipment in biotech and clinical laboratories.
Applied Stem Cells: Established a commercial structure and culture that aligned with the investor owner’s goals for increasing revenue.
Copyright © 2024, Bedrock Discovery. All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.